Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28228740 | 0.80 | BBOX1 (0.37) | CA4TSHRCA2 | |
| Fluoromethane SCHEMBL27524847 | 0.78 | TP53 (0.35) | CA4TSHRCA2 | |
| SCHEMBL29127374 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| Water SCHEMBL27621442 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| Hydrochloric Acid SCHEMBL27735116 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| Hydrochloric Acid SCHEMBL28762594 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| SCHEMBL27265066 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| SCHEMBL28801712 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| Bromide SCHEMBL27618467 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 | |
| SCHEMBL28234151 | 0.77 | BBOX1 (0.35) | CA4TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11465966-B2 | Cyclopropanation method | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2022-10-11 | — | — | US | disclosed |
| US-20210238133-A1 | CYCLOPROPANATION METHOD | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2021-08-05 | — | — | US | disclosed |
| WO-2019035479-A1 | CYCLOPROPANATION METHOD | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2019-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11465966-B2 | Cyclopropanation method | ADH1A, ADH1C, ADH5 | CA4 311/4885TSHR 3404/4885CA2 672/4885 |
| US-20210238133-A1 | CYCLOPROPANATION METHOD | ADH1A, ADH1C, ADH5 | CA4 311/4885TSHR 3404/4885CA2 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.